Business
AstraZeneca to publish full US trial results after criticism of ‘outdated’ data use – Sydney Morning Herald
NIAID Director Dr Anthony Fauci called the whole issue a really unfortunate unforced error.
The data really are quite good but when they put it into the press release it wasnt completely accurate, he said.
In addition to the 79 per cent efficacy in stopping symptomatic illness in the trial conducted in the United States, Chile and Peru, the data reported on Monday also showed the shot was 100 per cent effective against severe or critical forms of the disease and posed no increased risk of blood clots.
On Sunday, Australias Therapeutic Goods Administration approved the locally manufactured…
-
Noosa News21 hours agoTributes for woman allegedly mowed down on footpath in Maroochydore; Guilherme Dal Bo charged
-
General19 hours agoMan refused bail charged with depicting Adolf Hitler and Nazi symbols on boat
-
General15 hours agoTwo people arrested after man fatally shot at McLaren Flat
-
General13 hours agoWarner Bros Discovery board rejects rival $163bn bid from Paramount
